NATURE’S SUNSHINE PRODUCTS, INC. Inventory, Finished Goods, Net of Reserves
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Inventory, Finished Goods, Net of Reserves of $47.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $47.62M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $45.09M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $44.17M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $43.25M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $47.62M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $45.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $44.17M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $43.25M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $43.62M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $40.40M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $37.12M 10-K · filed 2026-03-10 |
| 2024-09-30 | $43.48M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $44.38M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $43.41M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $47.38M 10-K · filed 2025-03-11 |
| 2023-09-30 | $46.17M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $43.72M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $43.73M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $43.10M 10-K · filed 2024-03-12 |
| 2022-09-30 | $39.33M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $41.03M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $36.92M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $36.61M 10-K · filed 2023-03-16 |
| 2021-09-30 | $36.15M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $32.86M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $30.65M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $32.38M 10-K · filed 2022-03-08 |
| 2020-09-30 | $32.89M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $34.18M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $30.84M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $31.91M 10-K · filed 2021-03-10 |
| 2019-09-30 | $31.35M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $31.04M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $30.34M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $30.11M 10-K · filed 2020-03-11 |
| 2018-09-30 | $30.48M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $28.94M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $31.74M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $32.37M 10-K · filed 2019-03-08 |
| 2017-09-30 | $37.69M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $36.85M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $34.58M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $31.91M 10-K · filed 2018-03-16 |
| 2016-09-30 | $31.21M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $29.24M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $26.63M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $24.36M 10-K · filed 2017-03-14 |
| 2015-09-30 | $26.51M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $27.14M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $28.89M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $28.70M 10-K · filed 2016-03-14 |
| 2014-09-30 | $28.47M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $27.79M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $29.04M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $30.32M 10-K · filed 2015-03-13 |
| 2013-09-30 | $30.89M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $28.90M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $28.35M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $29.25M 10-K · filed 2014-03-17 |
| 2012-09-30 | $28.91M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $28.05M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $27.39M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |